Revenue - INVO Bioscience Inc (NASDAQ:INVO) - Alpha Spread

First Time Loading...

Watchlist Manager

Watchlist

Price: 0.98 USD -0.01%

Updated:

INVO Bioscience Inc
Revenue

Last Value

3-Years 3-Y CAGR

5-Years 5-Y CAGR

10-Years 10-Y CAGR

Quarterly

Annual

TTM

|

Adjust for Inflation

INVO Bioscience Inc
Revenue Peer Comparison

BDX

BSX

SYK

ABT

ISRG

Company		Revenue	CAGR 3Y	CAGR 5Y	CAGR 10Y
	INVO Bioscience Inc NASDAQ:INVO	Revenue $3m	CAGR 3-Years 43%	CAGR 5-Years 44%	CAGR 10-Years N/A
	Becton Dickinson and Co NYSE:BDX	Revenue $19.5B	CAGR 3-Years 4%	CAGR 5-Years 3%	CAGR 10-Years 9%
	Boston Scientific Corp NYSE:BSX	Revenue $14.2B	CAGR 3-Years 13%	CAGR 5-Years 8%	CAGR 10-Years 7%
	Stryker Corp NYSE:SYK	Revenue $20.5B	CAGR 3-Years 13%	CAGR 5-Years 9%	CAGR 10-Years 9%
	Abbott Laboratories NYSE:ABT	Revenue $40.3B	CAGR 3-Years 3%	CAGR 5-Years 6%	CAGR 10-Years 8%
	Intuitive Surgical Inc NASDAQ:ISRG	Revenue $7.3B	CAGR 3-Years 17%	CAGR 5-Years 14%	CAGR 10-Years 13%

INVO Bioscience Inc
Revenue Breakdown

Total Revenue: 3m USD

100%

Clinic Revenue: 2.9m USD

94.8%

Product: 158k USD

5.2%

See Also

Based on the financial report for Dec 31, 2023, INVO Bioscience Inc's Revenue amounts to 3m USD.

Over the last year, the Revenue growth was 268%. The average annual Revenue growth rates for INVO Bioscience Inc have been 43% over the past three years , 44% over the past five years .

Join more than 132,400+ value investors using Alpha Spread

Create a free account

or see our plans & pricing

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

What is Intrinsic Value? Help Center Contact Us

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.